Use of iron sucrose in dialysis patients sensitive to iron dextran
This study aimed to assess the safety and efficacy of iron sucrose in hemodialysis (HD) patients with documented hypersensitivity reactions to iron dextran. Of 205 HD patients who received low molecular weight iron dextran, 15 (7.3%) patients developed documented hypersensitivity reaction...
Main Authors: | Haddad Ayham, Abbadi Rabe′a, Marji Ann |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2009-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Subjects: | |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2009;volume=20;issue=2;spage=208;epage=211;aulast=Haddad |
Similar Items
-
Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an <it>in-vitro </it>study
by: Grabe Darren W, et al.
Published: (2004-01-01) -
Safety and Efficacy of Intravenous Iron Sucrose versus Low Molecular Weight Iron Dextran for Treatment of Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial
by: Samsudin S, et al.
Published: (2020-12-01) -
Comparison of short-term efficacy of iron sucrose with those of ferric chloride in hemodialysis patients: An open-label study
by: Po-Jen Hsiao, et al.
Published: (2016-01-01) -
Iron Sucrose Versus Oral Iron Therapy in Pregnancy Anemia
by: Syal Neeru, et al.
Published: (2012-01-01) -
Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
by: Jesse M. G. Hofman, et al.
Published: (2018-09-01)